Viral Vector Development, Manufacturing, And Process Intensification

By Miriam Monge, Amélie Boulais, and Gerben Zijlstra

In 2018, Sartorius Stedim Biotech (SSB) hosted a seminar for viral vaccine manufacturers at the Novotel, Amsterdam, the Netherlands. The seminar featured three guest presentations from ABL Europe, Janssen Vaccines, and the Max Plank Institute, Magdeburg. These external presenters spoke alongside experts in vaccine processes and process intensification from SSB. Continue reading for an overview of the tools and technologies available for development of viral vectors and to provide insights into techniques that viral vector manufacturers can use to intensify their production processes to achieve greater productivity.